AuthorsTrainer, Peter J
AffiliationDepartment of Endocrinology, The Christie NHS Foundation Trust, Manchester, United Kingdom.
MetadataShow full item record
AbstractA number of drugs have been advocated for the medical management of Cushing's syndrome but few have gained widespread acceptance. The most reliably effective agents are metyrapone and ketoconazole as monotherapy, or in combination. Cabergoline may be of value in a minority of patients but pasireotide is a more reliable and effective agent that lowers cortisol secretion in the great majority of patients, although only normalises UFC in a minority. The potential for combination of an agent that blocks adrenal steroidogenesis with inhibition of ACTH secretion by pasireotide needs to be explored.
CitationNew options for the medical treatment of Cushing's syndrome. 2013, 17 (2):245-8 Indian J Endocrinol Metab
JournalIndian Journal of Endocrinology and Metabolism
- Cushing's disease: current medical therapies and molecular insights guiding future therapies.
- Authors: Lau D, Rutledge C, Aghi MK
- Issue date: 2015 Feb
- Drugs in the medical treatment of Cushing's syndrome.
- Authors: Schteingart DE
- Issue date: 2009 Dec
- Mitotane, metyrapone, and ketoconazole combination therapy as an alternative to rescue adrenalectomy for severe ACTH-dependent Cushing's syndrome.
- Authors: Kamenický P, Droumaguet C, Salenave S, Blanchard A, Jublanc C, Gautier JF, Brailly-Tabard S, Leboulleux S, Schlumberger M, Baudin E, Chanson P, Young J
- Issue date: 2011 Sep
- Medical treatment of Cushing's syndrome: adrenal-blocking drugs and ketaconazole.
- Authors: Feelders RA, Hofland LJ, de Herder WW
- Issue date: 2010
- Therapy of Cushing's syndrome with steroid biosynthesis inhibitors.
- Authors: Engelhardt D, Weber MM
- Issue date: 1994 Jun